Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares

INFORMATION REGLEMENTEE


[02/10/2020 | 20:03]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6em3cSlvECDOVCQbAvnN3JCLb3mgJLu0HQMiQ20Nk4E5dljRlUvxZ5qw=
WL0nreVb9dC-2F2YrEPV-2BEAZDEn-2FKlLL1wcz4Q_xDPID0vOuylFAU8fv4e60wei4JxqEGBd=
VWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9=
c9g1wb5PTJZSRDnA93IUtdqAsE9j1T5ix8bIAxiObY18li-2Bv0-2FIGKpEoy45cCl9p9m0TiW1=
QXGIhTqLtnvr0oYE6uKqyKmQKwXNE-2FPx7jYMmbcH4xCsKtM-2FTTfj0wgTATTt8UVUM-2FnfE=
qLsg8qWKxJkl5yEtaAikCWqj6zrUkUag3QTZWasNiEcQevZb6sFVzWBzxdZ-2Bed9ku5GeY5qiB=
Ddnh3elxxhUM60h6p6Wbn4FTFACdNB7KYHoxcuCmhs1eS109c-3D

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 2 October 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regulat=
ed information
In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB SA/NV (=E2=80=9CUCB=E2=80=9D or the =
=E2=80=9CCompany) (Euronext Brussels: UCB) announces that, following exerci=
ses of stock options by members of its personnel, it has disposed of UCB sh=
ares OTC in view of deliveries of these shares to the relevant members of t=
he personnel, within the framework of the Long Term Incentive Program of th=
e UCB Group, as follows:
=C2=A0
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6em3cSlvECDOVCQbAvnN3JCLG5t22-2BJQ4X-2Fspu4-2B-2BmRKEVsN=
Sg7TwT2y1yOsosirEtQGqSC5fzWz6q3p1bikX0m1fL2s_xDPID0vOuylFAU8fv4e60wei4JxqEG=
BdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2=
X9c9g1wb5PTJZSRDnA93IUtdqAsE9j1T5ix8bIAxiObY18li-2Bv0-2FIGKpEoy45cCl9p9m0Ti=
W1QXGIhTqLtnvr0oYE6uKqyKmQKwXNE-2FPx7jYMmbcH41GMfNtQzD5QT0yJ22NBViSBaMJM08K=
WX6fUeeTUN1nprTDXVAhaKok2rhq-2BUfg7Vud7lgZTpmutnU5byM0U0uSim7fbdCNkZJ5G8l3K=
C4oZQzTDRMuxqh7Az4ALq50S8RJjWU6sO6JSTrqQHYvCQkc-3D

This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ=
yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1=
8dK5MiuQ-3D-3DGdHD_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wb5PTJZSRDnA93IUtdqA=
sE9j1T5ix8bIAxiObY18li-2Bv0-2FIGKpEoy45cCl9p9m0TiW1QXGIhTqLtnvr0oYE6uKqyKmQ=
KwXNE-2FPx7jYMmbcH41EKE-2Fhnchk57mQEKvj7dyw-2Fv7BzNvmudCgRVgleuYfBbIZguPlyY=
LKdYH01NcFGznzSTSZ77Q1Tr3P8R1xXSjMJgt4i78DPgWGXPBrSvB3hy-2BB7YNehmccAdEkgRL=
auoA06IZ8d0Pld-2BwjkxEf-2F6JA-3D .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i=
n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news

GenericFile
201002 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click=
?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6em3cSlvECDOVCQbAvnN3J=
CLiI4tf9bYE9s8Y6Lntd6Erd3i9syObp8pWYBWI8l-2Bdi8-3D-njx_xDPID0vOuylFAU8fv4e6=
0wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9=
ekocVj-2F2X9c9g1wb5PTJZSRDnA93IUtdqAsE9j1T5ix8bIAxiObY18li-2Bv0-2FIGKpEoy45=
cCl9p9m0TiW1QXGIhTqLtnvr0oYE6uKqyKmQKwXNE-2FPx7jYMmbcH43A4sVw36h45dt8tHMRnq=
whyF1n1-2FHKoJaFPc0EXnIPM2Hg2wh8g7jF8OGPJOrqw3ej9GTAlHsPmPfyYr9k6XU8pIwXr4h=
sEZODv-2F9U4hGEX93x4zxfkn9-2BkdwguRmG2vG64ch7ZBxx9zvH4IVfL2xI-3D GenericFile
201002 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.ne=
t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6em3cSlvECDO=
VCQbAvnN3JCLVd47QXv9J-2Fafy0OY8ZBiW5dom8rtClSFF6PevO3lNO0-3DZJ-Z_xDPID0vOuy=
lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf=
-2FOeoCOG9ekocVj-2F2X9c9g1wb5PTJZSRDnA93IUtdqAsE9j1T5ix8bIAxiObY18li-2Bv0-2=
FIGKpEoy45cCl9p9m0TiW1QXGIhTqLtnvr0oYE6uKqyKmQKwXNE-2FPx7jYMmbcH4wEkhUvuSvT=
GIZ2Tg-2BcR-2FHlZUdzukzDxxBsn5OTojnFBoY8LgDnEVHl8wIgwoXKI0lQ-2Bv31fMLLq43b-=
2B4Sn4Y0-2FzSolf-2FFE-2Bkgp21Do3dDXLD1LGeoqOAD3xBsikay5vsD1PB54hcnqWc0ahE3u=
OIu4-3D GenericFile
201002 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/=
ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6em3cSlvECDOVC=
QbAvnN3JCLyDShLsyVyWHzWFuVbYKqJRCKnVrtqUaJz8Kpw7s1uI4-3DHF87_xDPID0vOuylFAU=
8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FO=
eoCOG9ekocVj-2F2X9c9g1wb5PTJZSRDnA93IUtdqAsE9j1T5ix8bIAxiObY18li-2Bv0-2FIGK=
pEoy45cCl9p9m0TiW1QXGIhTqLtnvr0oYE6uKqyKmQKwXNE-2FPx7jYMmbcH48bd9Zjq2UB-2BV=
WA2tueG0s5Se83bFDhw8uaCJVti0U-2BF0MWuJvLVOmDemZm1jFRplGG0WInl5uxdUqeTsAlAQc=
oyA7W6wpFo-2FWuXj4DAvsSALnigburccU4-2Bwk7M-2BF9M6nj0OhWjOUtTzANsCtyoDB4-3D =
Image
Chart 1 October 2 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tN=
ED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6em3cSlvECDOVCQbAvnN3JCLG5t22-2B=
JQ4X-2Fspu4-2B-2BmRKEcEYG-2F25m-2FPCRHrf4lJohi0-3Dd3v__xDPID0vOuylFAU8fv4e6=
0wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9=
ekocVj-2F2X9c9g1wb5PTJZSRDnA93IUtdqAsE9j1T5ix8bIAxiObY18li-2Bv0-2FIGKpEoy45=
cCl9p9m0TiW1QXGIhTqLtnvr0oYE6uKqyKmQKwXNE-2FPx7jYMmbcH4xhF5lpAlN4AVJVnK-2FQ=
JCJmEEjVSKG-2F11OqOayy2i7ZHovn2rpB7NC9z3WWOqKyPDQBoBam79xe8-2B7QQdbaxil8t1J=
ihmFCJZiMdgTYufE2N8wCObfJ6Zu6Tsc76unMF-2Fk2l99d4FWm5KLH7S-2BYEjzA-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXeaP1ilaXWoqKhipDncJCEz51x1YlVoV=
QkTmG3UfV1T-2BXS-2FwP6aQF1O3hJmTBmQX9qqWxUBDocq1t73t1nlSsSUQHeVhS-2FKZGMxu6=
-2FCm6M3I-3D6_uX_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0=
KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wb5PTJZSRDnA93IUtdqAsE=
9j1T5ix8bIAxiObY18li-2Bv0-2FIGKpEoy45cCl9p9m0TiW1QXGIhTqLtnvr0oYE6uKqyKmQKw=
XNE-2FPx7jYMmbcH41u2NbiepXkKdmVHDDQ0hpAzLt53n2ZDsnSuFS26aOp7fNAl4FBlYjRXhuX=
xmIIWw8jsDCozmjEc6itxl8Hi6pJnhliyjMdlqsK638nYSikq4P9cgIGOyY24qBXTdvkYnE9JLs=
BT7hAe6UmvhWGJYlQ-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=